CDH1 and breast cancer: Similarly, saRNAs targeting the −215 region of the CDH1 promoter in breast cancer led to cells having a decreased proliferation rate, increased apoptosis and decreased migration capabilities, compared with mock-transfected and control sequence transfected cells, as well as a potent growth inhibitory effect in vivo.26